MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    The association between perceived walking difficulties and gait speed in people with drug naïve/early PD

    SB. Jonasson, M. Lindh-Rengifo, E. Stomrud, O. Hansson, MH. Nilsson (Lund, Sweden)

    Objective: To investigate the association between perceived walking difficulties and gait speed in people with drug naïve or early Parkinson’s disease (PD). Background: Objective aspects…
  • 2023 International Congress

    Development and Evaluation of a Digital Resource Library for Arkansans with Parkinson Disease and Their Caregivers

    S. Dhall, A. Diamond, T. Virmani, R. Sloan, T. Burrow, J. Chacko, C. Fullen, T. Reckling, J. Holton, H. Pickett, H. Petersen, K. Coleman, D. Mcclendon, D. Chandler, E. Echols, C. Gauss, K. Donovan, S. Parveen, R. Dhall (Little Rock, USA)

    Objective: To develop and evaluate impact of a Digital Resource Library (DRL) to address unmet needs for disease state education of People with PD (PwP)…
  • 2023 International Congress

    Correlations between bradykinesia and acoustic speech variables in advanced Parkinson’s Disease

    F. Cavallieri, G. Di Rauso, A. Gessani, C. Budriesi, V. Fioravanti, S. Contardi, E. Menozzi, S. Pinto, E. Moro, F. Antonelli, F. Valzania (Reggio Emilia, Italy)

    Objective: To find the presence of possible correlations between upper extremity bradykinesia and speech variables in different medication conditions in a cohort of advanced Parkinson’s…
  • 2023 International Congress

    Association between supine hypertension and plasma free triiodothyronine in drug-naïve Parkinson’s disease

    T. Umehara, T. Kokubu, J. Takahashi, T. Shiraishi, T. Sato, A. Onda, I. Iguchi (Tokyo, Japan)

    Objective: We aimed to clarify the association between thyroid hormone levels and supine hypertension (SH) in patients with early Parkinson’s disease (PD). Background: Increasing evidence…
  • 2023 International Congress

    The effect of taVNS on gait in advanced Parkinsons disease – a double blind, sham controlled motion sensors study in 30 patients

    V. van Midden, Z. Pirtošek, U. Simončič, M. Kojović (Ljubljana, Slovenia)

    Objective: In this double blind, sham controlled study on 30 advanced Parkinson’s disease (aPD) patients we used inertial motion sensors (IMS) to characterize the effect…
  • 2023 International Congress

    Identifying prodromal NMS in a population-based recruitment strategy: Kassel data of Healthy Brain Ageing

    S. Schade, C. Vega Moreno, C. Horlings, A. Garrido, T. Marques, P. Mahlknecht, E. Bryan, C. Gomes, C. Pauly, S. Ghosh, K. Rege, R. Rawal, T. Wicke, E. Lang, S. Schnell, V. Satagopam, K. Seppi, M. Marti, E. Tolosa, W. Poewe, R. Krüger, C. Trenkwalder, B. Mollenhauer (Kassel, Germany)

    Objective: To identify subjects with NMS for recruitment of a cohort at risk for prodromal PD Background: Neurodegeneration in PD starts years before the development…
  • 2023 International Congress

    Orthostatic hypotension exacerbates gray matter atrophy related to REM sleep behavior disorder in de novo Parkinson’s disease

    T. Shiraishi, T. Umehara, Y. Iguchi (Tokyo, Japan)

    Objective: As the previous studies indicated that other factors including REM sleep behavior disorder (RBD) and olfactory dysfunction were also associated with cognitive decline and…
  • 2023 International Congress

    Genetics of Parkinson’s Disease in Polish patients with positive family history-preeliminary study.

    L. Milanowski, D. Hoffman-Zacharska, M. Geremek, S. Szlufik, A. Friedman, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of our study was to find genetic variants associated with the familial forms of Parkinson’s disease (PD) in Polish population. Background: PD…
  • 2023 International Congress

    Clinico-genetic analysis of patients with Parkinson’s disease and GBA mutations from a tertiary care teaching centre in India

    S. Kamath, V. Holla, P. Phulpagar, N. Kamble, R. Yadav, B. Muthusamy, PK. Pal (Bangalore, India)

    Objective: To describe the clinico-genetic association of PD patients with heterozygous GBA mutations (PDwG). Background: Parkinson’s disease (PD) is currently understood to be the outcome…
  • 2023 International Congress

    Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life

    R. Ou, C. Li, Q. Wei, K. Liu, J. Lin, T. Yang, Y. Xiao, Q. Jiang, Y. Cheng, Y. Hou, L. Zhang, W. Song, X. Chen, X. Lai, H. Shang (Chengdu, China)

    Objective: Mutations in glucocerebrosidase (GBA) can change the phenotype of Parkinson’s disease (PD). This study aimed to explore the clinical characteristics of freezing of gait…
  • « Previous Page
  • 1
  • …
  • 279
  • 280
  • 281
  • 282
  • 283
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley